Literature DB >> 16152710

Altered mitochondrial RNA production in adipocytes from HIV-infected individuals with lipodystrophy.

Lorenzo Galluzzi1, Marcello Pinti, Giovanni Guaraldi, Cristina Mussini, Leonardo Troiano, Erika Roat, Chiara Giovenzana, Elisa Nemes, Milena Nasi, Gabriella Orlando, Paolo Salomoni, Andrea Cossarizza.   

Abstract

BACKGROUND: Damage to mitochondria (mt) is a major side effect of highly active antiretroviral therapy (HAART) that includes a nucleoside reverse transcriptase inhibitor (NRTI). Such damage is associated with the onset of lipodystrophy in HAART-treated HIV+ patients. To further investigate mt changes during this syndrome, we analysed the expression of mtRNA in adipocytes from lipodystrophic HIV+ patients taking NRTI-containing HAART and compared it with similar cells from healthy individuals.
MATERIALS AND METHODS: Total RNA was extracted from adipocytes collected from different anatomical locations of 11 HIV+ lipodystrophic patients and seven healthy control individuals. RNA was reverse transcribed and Taqman-based real-time PCR was used to quantify three different mt transcripts (ND1, CYTB and ND6 gene products). mtRNA content was normalized versus the housekeeping transcript L13.
RESULTS: ND1, CYTB and ND6 expression was significantly reduced in HIV+ lipodystrophic patients. HIV+ men and women did not differ in a statistically significant way regarding the levels of ND1 and ND6, whereas the opposite occurred for CYTB.
CONCLUSIONS: Lipodystrophy following treatment with NRTI-containing HAART is associated with a decrease in adipose tissue mtRNAs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16152710

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  6 in total

1.  Mitochondrial oxidative phosphorylation protein levels in peripheral blood mononuclear cells correlate with levels in subcutaneous adipose tissue within samples differing by HIV and lipoatrophy status.

Authors:  Cecilia M Shikuma; Mariana Gerschenson; Dominic Chow; Daniel E Libutti; John H Willis; James Murray; Roderick A Capaldi; Michael Marusich
Journal:  AIDS Res Hum Retroviruses       Date:  2008-10       Impact factor: 2.205

2.  Subcutaneous Adipocyte Adenosine Triphosphate Levels in HIV Infected Patients.

Authors:  Greg S Gojanovich; Cecilia M Shikuma; Cris Milne; Daniel E Libutti; Dominic C Chow; Mariana Gerschenson
Journal:  AIDS Res Hum Retroviruses       Date:  2019-09-17       Impact factor: 2.205

Review 3.  Ageing and inflammation in patients with HIV infection.

Authors:  M Nasi; S De Biasi; L Gibellini; E Bianchini; S Pecorini; V Bacca; G Guaraldi; C Mussini; M Pinti; A Cossarizza
Journal:  Clin Exp Immunol       Date:  2016-08-09       Impact factor: 4.330

4.  Mitochondrial DNA content, an inaccurate biomarker of mitochondrial alteration in human immunodeficiency virus-related lipodystrophy.

Authors:  Min Ji Kim; Claude Jardel; Cyrille Barthélémy; Véronique Jan; Jean Philippe Bastard; Sandrine Fillaut-Chapin; Sydney Houry; Jacqueline Capeau; Anne Lombès
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

5.  Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection.

Authors:  Grace A McComsey; Daniel E Libutti; MaryAnn O'Riordan; Jessica M Shelton; Norma Storer; Jason Ganz; John Jasper; Danielle Harrill; Mariana Gerschenson
Journal:  Antivir Ther       Date:  2008

Review 6.  Pathogenesis and management of lipoatrophy.

Authors:  Marisa Tungsiripat; Grace McComsey
Journal:  Curr HIV/AIDS Rep       Date:  2008-05       Impact factor: 5.495

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.